Bernhard Müllinger
General Manager and Chief Operating Officer

About

Bernhard Müllinger is General Manager and Chief Operating Officer at Resyca. With over 30 years of experience in aerosol drug delivery, he has held senior positions at Vectura, Activaero and Inamed, and serves on the board of the International Society for Aerosols in Medicine. His expertise covers device engineering, deposition modeling, and the development of drug-device combination products for respiratory and nasal applications.

Contributions

PULMONARY

ENHANCING DRUG DELIVERY WITH INNOVATIVE SOFT MIST INHALER TECHNOLOGY

Dr Nicolas Buchmann and Bernhard Müllinger, discuss the capabilities of soft mist inhalers in terms of usability for patients, sustainability, compatibility with biologics and cost-effective delivery, showcasing these advantages in Resyca’s Pre-Filled Syringe Inhaler (PFSI).

More contributions

EXPERT VIEW

DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?

Wilbur de Kruijf and Bernhard Müllinger discuss the the market requirements for new inhalation options and the benefits of soft mist inhalers.